Seres Therapeutics Information
Contact top employees from
Seres Therapeutics
Summary
Seres Therapeutics is a public company that has been in the industry for 15 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position of the President & CEO is occupied by Eric D. Shaff. Its headquarters is located at Cambridge, Massachusetts, USA. The number of employees ranges from 100 to 250. The annual revenue of Seres Therapeutics varies between 25M and 100M. Total funding of the company - $267.9M. To connect with Seres Therapeutics employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
Biotechnology, Therapeutics, Microbiome
SIC Code
2836
DMA Code
Greater Boston
Founded
2010
Estimated Annual Revenue
$25M - 100M
Operating Status
Independent Company
Contact Seres Therapeutics
Organization Website
Social Links
Phone Number
1-617-945-9626
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2015 | Privately Held | 100 - 250 | 8M | $85M | |
| 2006 | Public Company | 100 - 250 | 15.8M | $40.8M | |
| 2005 | Privately Held | 100 - 250 | 2.1M | $6.8M | |
| 2011 | Privately Held | 25 - 100 | 2.9M | $40M | |
| 2007 | Public Company | 25 - 100 | 15M | $210.9M | |
| 2015 | Privately Held | 25 - 100 | 7M | $173.5M | |
| 2015 | Public Company | 25 - 100 | 1.5M | $211.5M | |
| 2009 | Privately Held | 25 - 100 | 12M | $68.7M | |
| 2010 | Privately Held | 25 - 100 | 8M | $308.6M | |
| 1998 | Public Company | 100 - 250 | 57.8M | $405.9M | |
| 2015 | Privately Held | 1-10 | < 1M | $1.2M | |
| 2015 | - | 100-200 | - | $- | |
| 2011 | - | 500-1000 | - | $- | |
| 2013 | - | 200-500 | - | $- | |
| 2020 | - | 10-50 | - | $- | |
| 2017 | - | 10-50 | - | $- | |
| 2017 | - | 100-200 | - | $- | |
| 2014 | - | 100-200 | - | $- | |
| - | - | 10-50 | - | $- | |
| - | - | 5000-10000 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Ex-employees switched to
Length of Employment
Employee tenure at Seres Therapeutics shows a diverse range of experience levels:
1% have been with the company for less than 1 year9% for 1–2 years47% for 3–4 years12% for 5–7 years23% for 8–10 years7% have over 11 years of service at Seres TherapeuticsEx-employees positions
In Company
In New Company
Contact top employees from
Seres Therapeutics
Lauren OKeefe
Director Validation
Jackie Cunniff
Senior Principal Associate, QA
Alyssa DEramo
Vice President, Corporate Controller
Dale Bayless
Director, Global Supply Chain
Dave Singh
Principal Quality Assurance Specialist
Ravi Patel
Associate Director of Marketing
Terri Young
Executive Vice President, Chief Commercial and Strategy Officer
Samir alEryani
Director, Donor Laboratory Sciences
Sherry Weigand
SVP, Head of Clinical Science
Karin Graefe
Sr. Manager, Clinical Data Management (through 10/2024)
Jill Colabella
Executive Director, Clinical Operations
Melissa Gee
Director, Analytical Development, Science, and Technology, Donor Program, CMC
Laurel Prentice
Quality Assurance Specialist II
David Blake
Director External QA Operations
Kerri ODette
Senior Director, Clinical Operations, Compliance and Oversight
John Lalumiere
Vice President, FP&A
David Hardy
Manager, Donation Operations Quality Assurance
Nehemie Bernard
Executive Assistant
Qi Wei Leong
Senior Associate, CMC Manufacturing
David Lyttle
Senior Scientist, Computational Microbiome Sciences at Seres Therapeutics
David Knauss
Sr. Director, Regulatory Operations
Ann Kurowski
Sr. Vice President Regulatory Affairs
Emmeline Nease BSN
Nurse Specialist II
Kelley Whitman
Vice President, People & Culture Partnership
Jacqueline Drew
Clincial Trial Associate
Tori Mokrisky
Associate Director, Total Rewards & People Operations
Frank Penna
Senior Associate Procurement
Kelsey Barrasso
Scientist II, Host-Pathogen Interactions
Similar Companies
FAQ
Seres Therapeutics operates in the Biotechnology industries. More details can be found on the official website: serestherapeutics.com.
The headquarters of Seres Therapeutics are located in Cambridge, United States.
The current CEO of Seres Therapeutics is Eric D. Shaff
You can contact Seres Therapeutics by phone at 1-617-945-9626.
Seres Therapeutics currently employs 100-200 people.
Seres Therapeutics's revenue is approximately 30M.
Well-known competitors of Seres Therapeutics include DayTwo, Advanced Cell Diagnostics (ACD), Menarini Silicon Biosystems and Rebiotix Inc (a Ferring Company).
